Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Redosing EXPAREL in Healthy Volunteers
NCT02210247Phase 1Completed
- Sponsor
- Pacira BioSciences
- Start
- Aug 2014
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of liposomal bupivacaine in Persistent postsurgical pain (PPSP) (5 cohorts), sponsored by Pacira BioSciences. Primary endpoints: Maximum Plasma Concentration, Time to Maximum Concentration and 3 more. Started Aug 2014; status: completed.
02
Drugs
liposomal bupivacaine
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on NCT02210247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02210247.